Start with a clear need

• Tell me in one sentence the outcome you need from a contract blender or repackager right now.
• Walk me through the product or SKU you want us to produce, including form (liquid, paste, powder), typical concentration, and any critical ingredients.
• How many kilograms or units do you move in a typical month for this SKU? Options: Under 1,000 kg, 1,000 to 5,000 kg, 5,000 to 20,000 kg, 20,000 to 100,000 kg, Over 100,000 kg
• Identify the people in your organization who must sign off on formulation, quality, procurement, and shipping for a new supplier. Options: R&D / Formulation, Quality / QA, Procurement, Operations / Plant, Regulatory / Compliance, Sales / Product Management, Other
• When was the last time you changed a supplier or moved blending to a new facility, and what prompted that change?
• If a new blender could deliver to your specs, consistency, and lead time, how soon could you place the first purchase order? Options: Immediately, Within 30 days, 30 to 60 days, 60 to 90 days, Unsure

Which specification failure makes you walk away

• If one batch failed a critical specification, which consequence would make you stop using that vendor immediately? Options: Customer returns or complaints, Regulatory hold or recall, Production downtime at your plant, Contract penalties, No single consequence would stop us, Other
• Which measurable attributes must be met on every batch for this SKU, choose all that apply. Options: Concentration / active percent, pH, Viscosity, Solids content, Color / turbidity, Odor, Microbial limits, Heavy metals, Packaging integrity, Other
• How narrow are your acceptance bands for critical attributes such as concentration or pH? Options: Very tight (for example +/- 0.5% or tighter), Moderate (+/- 1 to 2%), Loose (+/- 3 to 5%), Flexible depending on lot, Not sure
• Which analytical methods should appear on the certificate of analysis, and do you supply those methods or expect the facility to use its validated methods? Options: Buyer provides full methods, Seller uses validated in-house methods, Buyer provides methods for actives only, Hybrid approach, Other
• Which team owns the master formula and change control, and how many formal formula versions do you expect to manage? Options: Buyer owns master formula, Joint ownership under NDA, Seller will house master formula under contract, No firm decision yet
• What single specification or test failure would make you reject an entire batch?

When contamination becomes a deal breaker

• Which contamination scenario would trigger a recall or stop production immediately? Options: Presence of a banned ingredient, Cross-contact with a declared allergen, Trace levels above your limit, Microbial contamination above spec, Unknown particulate or foreign material, Other
• Describe your tolerance for shared equipment, select the operating model you require for this SKU. Options: Dedicated equipment only, Shared with validated cleaning, Shared with quarantine and rework plan, No sharing allowed at all, Depends on product risk
• Walk me through the changeover and cleaning verification steps you expect, including any swab or rinse testing requirements.
• How should retained samples be handled and for how long would you require storage? Options: Retain 6 months, Retain 12 months, Retain 24 months, Buyer picks up retained samples, Other
• Which role should we contact first if we observe a possible contamination event during a trial? Options: Quality / QA contact, R&D / Formulation contact, Operations / Plant contact, Procurement contact, Regulatory contact, Other
• If the facility cannot guarantee the cleaning validation you require, would you accept a tightly controlled pilot or end the conversation? Options: Accept pilot under containment, Require documented validation before any pilot, End discussion, Unsure

Packaging and labeling that avoids surprises

• If a shipped lot arrived with incorrect labeling, which consequence would be most severe for your business? Options: Regulatory fine, Retail delisting or lost shelf placement, Customer returns and lost revenue, Safety incident or product hold, Minor rework with limited cost, Other
• Which packaging formats do you require for this SKU, select all that apply. Options: Drums, Pails, Totes / IBCs, Small bottles, Bulk bottles, Bags, Other
• How many unique label SKUs will this product need, and do you require serialized lot codes on each package? Options: 1 to 2 label SKUs, 3 to 5 label SKUs, More than 5 label SKUs, Require serialized lot codes on each package, Do not require serialization
• Do you require the vendor to produce DOT classification, safety data sheets, and hazmat shipping paperwork? Options: Yes, full vendor support required, Buyer provides DOT and SDS, Vendor prepares docs, buyer reviews, No, not required
• How long does label artwork and regulatory review typically take inside your organization? Options: 1 to 3 business days, 4 to 7 business days, 1 to 2 weeks, More than 2 weeks
• If packaging samples must pass compatibility and drop tests, do you have a required protocol or should the vendor propose one? Options: Buyer provides protocol, Vendor proposes protocol, Agree on a protocol together, No testing required

How trials need to prove trust

• If a trial batch shows variability between replicates, would you accept rework, request a repeat trial, or walk away? Options: Accept rework with documented corrective actions, Request a repeat trial at no cost, Walk away from the vendor, Depends on cause of variability
• Which QC tests must be completed during a trial, select all that apply. Options: Identity, Assay / active concentration, pH, Viscosity, Microbial limits, Heavy metals, Appearance and odor, Other
• How many trial batches do you typically expect before you will scale to production? Options: One trial batch, Two trial batches, Multiple until agreement, Depends on trial results
• Name the role that will sign off on trial results and how they prefer results to be delivered. Options: Quality with full report and raw data, R&D with technical dataset, Procurement with summary COA, Operations with in-process checks only, Other
• What acceptance criteria do you require for batch-to-batch consistency, for example relative standard deviation thresholds or maximum deviation limits?
• If a trial fails one acceptance criterion but passes all others, will that stop you from continuing with the vendor? Options: Yes, stop immediately, No, we will review corrective action, Depends on which criterion failed, Unsure

Commercial terms that either close the deal or sink it

• Which commercial term would make you walk away before a pilot? Options: MOQ is too high, Lead time is too long, Unit price unacceptable, Liability or indemnity terms unacceptable, Payment terms unacceptable, Other
• What is your target minimum order quantity for this SKU? Options: Under 500 kg, 500 to 2,000 kg, 2,000 to 10,000 kg, Over 10,000 kg
• What lead time do you need from order placement to ship for standard replenishment? Options: Less than 2 weeks, 2 to 4 weeks, 4 to 8 weeks, More than 8 weeks
• Which payment terms does your organization typically accept? Options: Prepaid, Net 30, Net 45, Net 60, Letter of credit, Other
• Who owns raw material sourcing for this product and will you provide preferred vendors or expect the contract blender to procure? Options: Buyer supplies raw materials, Seller sources per buyer spec, Hybrid arrangement, Other
• If price were 10% higher than your current supplier but quality and lead times improved materially, would you consider switching? Options: Yes, Maybe, need total cost analysis, No

Who else you are weighing (competitive landscape)

• Which supplier or approach are you most seriously evaluating right now, and why would that option win? Options: Incumbent external supplier, Building internal blending, Multiple small contract tollers, A new single vendor, Other
• What would need to be true about your current supplier for you to stay with them instead of switching? Options: Match price, Equal or better lead time, Documented quality history, Regulatory coverage in place, No change needed
• Has anyone on your team proposed building internal blending capacity instead of using a contract blender? Options: Yes, actively developing a build plan, Yes, discussed but no plan, No one has suggested that, Unsure
• If internal build is being considered, what timeline and investment estimates have been discussed? Options: Under 6 months and under $500k, 6 to 12 months and $500k to $2M, Over 12 months and over $2M, No estimate available
• Which single advantage would make you commit to staying internal rather than using an outside blender?

Operational readiness and constraints

• Which missing document or capability would prevent us from starting on your target schedule? Options: Finalized master formula, SDS and CofA for incoming materials, Validated analytical methods, Regulatory registrations, Label approvals, Purchase order or budget, Other
• Do you have a finalized master formula with exact component weights, sequence, and processing notes available for transfer? Options: Yes, complete formula available, Partial draft exists, No, formula needs development, Available only under NDA
• Do validated test methods exist for all required QC assays and who owns those methods? Options: Buyer owns validated methods, Seller has validated methods, Some owned by buyer some by seller, Methods not available yet
• Will your regulatory or legal teams require contract clauses about recalls, liabilities, or indemnities before a pilot can begin? Options: Yes, required, Maybe, depends on scope, No, not required, Unsure
• Can your quality team commit to reviewing and approving a trial COA within five business days? Options: Yes, No, Depends on scope, Unsure
• If readiness items are missing, which item should we prioritize fixing first to keep to your schedule?

If the pilot works, how do we close

• If a pilot batch meets all acceptance criteria and arrives on time, how quickly could your organization issue a purchase order and start regular replenishment? Options: Immediately, Within 2 weeks, 2 to 4 weeks, More than 4 weeks, Depends on contract negotiation
• Who are the decision makers, what are their roles, and what approval thresholds do they each control? Options: Quality sign-off required, Procurement approval threshold, Finance / budget holder, Operations / receiving sign-off, Regulatory / compliance approval
• What internal procurement or legal steps usually add time between pilot success and issuance of a purchase order? Options: Legal review and contract signing, Budget approval, Quality final approval, Supply chain evaluation and onboarding, Other
• What would you need from us to feel comfortable signing within 30 days after a successful pilot? Options: Complete trial COA and batch record, Signed quality agreement, Proof of insurance and regulatory documents, Final price and lead time confirmation, Other
• Which internal barrier could still block the deal even after a successful pilot?

• Manufacturing Walkthrough Session

• Confirm the current state and its cost
• You confirm whether the demonstrated equipment capabilities meet your formulation and batch-size requirements or identify specific capability gaps.
• Provide the full formulation spec, target trial batch size, and the acceptance criteria you will use for QC evaluation.
• You confirm whether the demonstrated changeover and contamination controls adequately mitigate cross-contamination risk or list the mitigations you require.
• Walk the blending equipment and process in your context
• Provide any regulatory constraints or required documentation (EPA/FDA/DOT classifications) that must be reflected in packaging and labeling.
• Walk the changeover and contamination controls
• Deliver a detailed equipment capability sheet, changeover SOPs, and proposed sampling locations within 3 business days.
• You agree on the exact QC tests, acceptance criteria, and retained-sample plan required for the trial batch.
• Walk packaging, labeling, and DOT/shipper controls in your context
• You agree on the next evidence and timeline required to schedule the Trial Batch & Lab Evaluation stage.
• Propose a target trial batch schedule and raw material lead times after receiving the formulation and acceptance criteria.
• Confirm QC tests, sampling plan, and acceptance criteria
• Validation question — does this match what you meant?
• Agree next evidence and timeline for the trial batch

• Manufacturing Walkthrough Session
• Manufacturing Walkthrough Deck
• Manufacturing Walkthrough Brief

• meeting
• slides
• document

• decision_readiness
• current_state
• desired_state
• success_criteria
• gaps
• stakeholders
• current_state
• gaps
• success_criteria
• desired_state
• stakeholders
• decision_readiness
• desired_state
• current_state
• gaps
• decision_readiness
• stakeholders
• success_criteria
• decision_readiness
• decision_readiness
• decision_readiness
• decision_readiness

• Batch Production to Customer Formula
• Temperature-Controlled Liquid Blending
• Powder Blending and Sieving
• Emulsification and Homogenization
• High-Viscosity Paste Mixing and Filling
• Bulk Repackaging into Drums, Pails, Bottles, Totes
• Small-Batch Pilot Production Runs
• Raw Material Sourcing and Inventory Hold
• pH Adjustment and Neutralization
• Filtration and Clarification
• Dedicated Line Changeover and Sanitization
• Quality Testing and Certificate of Analysis
• Batch Records and Retained Sample Storage
• Custom Labeling and Customer-Specified Packaging
• Hazmat Packaging and DOT Shipping Documentation

Batch Production to Customer Formula

• What is the exact bill of materials (BOM) for your formulation including CAS numbers and percent by weight for each ingredient?
• Do you require the facility to source any proprietary or restricted raw material on your behalf that must appear on the finished product Certificate of Analysis (CoA)? Options: Yes, No
• Which finished-batch sizes do you want produced during routine runs (e.g., 200 L, 1,000 L, 10,000 L)? Options: 200 L, 500 L, 1,000 L, 5,000 L, 10,000 L, Other
• How should we record the target assay and allowable tolerance for the key active ingredient (for example HPLC assay 98.0% ±0.5%) on the batch record?
• Who on your team will approve final formulation deviations or change requests and how should their approval be captured (signed batch record, electronic sign-off)? Options: Signed paper batch record, Electronic signature in platform, Email approval to attach, Other

Temperature-Controlled Liquid Blending

• What temperature range must be maintained during blending and hold steps (specify degrees Celsius) and for which stages (charge, mix, hold)?
• Do you require temperature mapping or validation records for the mixing vessel for this product class? Options: Yes, attach validation, No, not required
• Which viscosity target (in centipoise) or viscosity test method (e.g., Brookfield spindle and RPM) should be used to confirm blend acceptance?
• How long is the required temperature hold time at target temp for post-mix stabilization (specify minutes or hours)? Options: No hold, 15 minutes, 30 minutes, 1 hour, Custom
• Identify any cold-chain requirements for incoming raw liquids or finished goods (storage at 2-8°C, freezer, etc.). Options: Ambient, 2-8°C, Frozen < -18°C, Controlled but not refrigerated, Other

Powder Blending and Sieving

• Specify target particle size distribution or mesh size for the finished powder (e.g., 80% < 325 mesh) and associated test method.
• Do you require in-line or post-blend sieving and what maximum permitted oversized fraction is acceptable (percent by weight)? Options: No sieving, In-line sieving, Post-blend sieving, Both
• Which bulk density or tapped density range should be reflected on the CoA for packing and fill-weight calculations?
• How sensitive is your formulation to segregation; should we include a blend-uniformity test (e.g., RSD by assay ≤ X%) in the batch QC plan? Options: Yes, include uniformity test, No, not required
• Indicate any dust control or containment requirements (HEPA ventilation, local exhaust, enclosed transfer) required for your powder handling. Options: Standard dust control, HEPA filtered containment, Full enclosure/negative pressure, No special controls

Emulsification and Homogenization

• Describe the target droplet size distribution (D50 in microns) or emulsion class you require and the analytical method (e.g., laser diffraction).
• Explain required homogenizer settings or acceptance ranges (for example pressure in bar or rpm) that must be used or documented in the batch record.
• When do you require sampling for creaming/separation stability during pilot or production runs (e.g., after 24 hours, 7 days) and which stability endpoints matter? Options: 24 hours, 7 days, 30 days, Custom
• Are there specific emulsifier to oil ratios, HLB targets, or surfactant limits that must be enforced and recorded? Options: Yes, provide ratios, No fixed ratios
• Which physical tests should be included in QC for emulsions (viscosity, droplet size, pH, centrifuge separation), select all that apply. Options: Viscosity, Droplet size (laser diffraction), pH, Centrifuge separation, Microbial limit, Other

High-Viscosity Paste Mixing and Filling

• Specify the target Brookfield viscosity range (cP) or torque limit for the paste at fill temperature and the test spindle/RPM to use.
• Do you need heated transfer, jacketed vessel mixing, or static mixing for pumpability during filling into pails/totes? Options: No heating, Jacketed vessel, Heated transfer lines, Static mixing, Other
• Which fill-weight tolerance (absolute or percent, e.g., ±1% by weight) should be applied for pails and drums on the production lot? Options: ±0.5%, ±1%, ±2%, Custom
• Identify necessary filler type or nozzle size constraints to avoid shear-sensitive product damage during filling.
• Provide any headspace, deaeration, or vacuum requirements for your paste product before sealing containers. Options: No deaeration, Mild deaeration, Full vacuum deaeration, Other

Bulk Repackaging into Drums, Pails, Bottles, Totes

• Which container SKUs and sizes do you require for finished goods (list exact sizes and desired material: HDPE drum, metal drum, PET bottle, etc.)?
• Do you require tamper-evident closures, venting, liners, or specific gasket materials for any container SKU? Options: Tamper-evident, Vented caps, Liners, Specific gasket material, None
• How should lot numbers and manufacturing dates be formatted on container labels for your traceability system (example format: YYYYMMDD-Lot###)?
• Indicate required pack counts per pallet and any palletization constraints for LTL or FTL shipping.
• Choose any required fill verification checks at packaging (weight check, in-line leak test, visual inspection). Options: Weight check, In-line leak test, Visual inspection, Code scanner verification, None

Small-Batch Pilot Production Runs

• What pilot-scale batch sizes do you want for formulation verification (e.g., 5 L, 20 L, 50 L) and how many iterations are expected? Options: 5 L, 20 L, 50 L, Custom
• Do you require full CoA and stability testing on pilot batches or abbreviated analytics only? Options: Full CoA and stability, Abbreviated analytics, Customer decides per run
• Identify which process parameters must be recorded during pilots for scale-up (mix time, rpm, shear, temperature profile).
• Estimate acceptable small-batch variability thresholds that will allow scale-up to production (for example assay RSD ≤ X%).
• Specify whether you require preserved retained samples from each pilot batch and the sample size to hold (mL or g). Options: No retained samples, 250 mL / 250 g, 500 mL / 500 g, Other

Raw Material Sourcing and Inventory Hold

• Which raw material items must be vendor-approved with Certificates of Analysis (CoA) and Safety Data Sheets (SDS) before use (list by CAS or trade name)?
• Do you require the host to hold stock under consignment or will you pre-purchase and ship to the facility? Options: We consign materials, You procure and ship
• Indicate required quarantine and release criteria for incoming raw materials (e.g., identity test, assay within X%, SDS present).
• When is a vendor change acceptable for a given raw material and which documentation must accompany a substitution (vendor CoA, certificate traceability)? Options: Substitutions allowed with CoA, No substitutions without written approval
• Specify shelf-life or re-test period handling for critical raw materials and how we should display expiry on your lot traceability.

pH Adjustment and Neutralization

• What target pH and allowable pH range should be recorded on the CoA for the finished product (for example pH 7.2 ±0.2)?
• Do you require controlled addition steps for neutralization with in-process pH checks at defined volumes or timepoints? Options: Yes, staged additions with checks, No, final adjustment only
• Which titrant or acid/base chemicals are permitted for your formulation (list acceptable chemicals and concentrations)?
• Indicate whether you require automated pH logging (timestamped pH vs time) included in the batch record. Options: Yes, automated pH log, Manual pH reads recorded, No pH logging required
• Specify any acceptance criteria tied to pH-related stability or regulatory limits (for example preservative efficacy at pH range).

Filtration and Clarification

• Which final filtration pore size or filter rating is required (for example 0.45 μm, 5 μm) and for which product steps? Options: 0.2 μm, 0.45 μm, 1 μm, 5 μm, Other
• Do you require validation of filter integrity or log reduction claims for microbial removal on your product class? Options: Yes, validation required, No validation required
• Identify acceptable filter media and whether single-use filter housings are required for cross-contamination control. Options: Stainless reusable, Single-use disposable, Cartridge filters, Other
• When should clarification be performed (pre-fill, post-mix, post-heating) and which turbidity or clarity endpoint should be used?
• Specify documentation required for filtration steps (filter lot number, differential pressure log, lot COA attachment).

Dedicated Line Changeover and Sanitization

• Describe whether you need a dedicated line for your product or if validated shared-line changeover with clean-in-place (CIP) is acceptable. Options: Dedicated line required, Validated shared line with CIP
• Which cleaning acceptance metric must be met before changeover (ATP swab RLU threshold, TOC ppm, visual inspection)?
• How much documented lead time do you need for scheduling a dedicated run that requires full line sanitization? Options: 48 hours, 72 hours, 1 week, Custom
• Identify required sanitants or sterilants allowed on equipment in contact with your product (e.g., peracetic acid, isopropanol) and any residue limits.
• Specify what evidence you require for changeover completion (cleaning SOP, signed cleaning log, swab test result upload). Options: Cleaning SOP + log, Swab test results, Photographic evidence, All of the above

Quality Testing and Certificate of Analysis

• What specific QC tests must appear on the CoA for each finished batch (select from assay by HPLC, density, pH, microbial limits, heavy metals ICP-MS, FTIR fingerprint)? Options: Assay (HPLC), pH, Density, Viscosity, Microbial limits (CFU/g), Heavy metals (ICP-MS), FTIR fingerprint, Other
• Confirm the maximum number of analytically critical attributes for which out-of-specification handling will require a formal investigation and customer notification. Options: 1 attribute, 2 attributes, Any OOS triggers notification
• Which accredited laboratory methods or compendial standards do you require for key assays (include method reference or internal method name)?
• Provide the turnaround time required for final CoA issuance after sample receipt (e.g., 48 hours, 5 business days). Options: 24 hours, 48 hours, 72 hours, 5 business days, Custom
• What are the acceptance criteria for finished-batch release that define 'done' (for example assay ≥98%, microbial <100 CFU/g)?

• Manufacturing Services Agreement (MSA)
• Order Confirmation / Purchase Agreement
• Pricing, MOQ & Payment Schedule
• Quality, Testing & Acceptance Addendum
• Regulatory Compliance & Liability Addendum
• Raw Material Sourcing & Title Transfer Agreement
• Change Order & Production Change Process
• Shipping, Packaging & Hazardous Goods Terms

• Production Health Check (weeks 1-4 post first run)
• First Measurement Review (weeks 4-10)
• 90-Day Stabilization Review
• Quarterly Ongoing Quality and Support Review

• Update the replenishment forecast to address any gaps against committed lead times and minimum order quantities.
• Re-confirm agreed success criteria and owners
• Present 90-day outcome summary
• Validate that closed remediation items have resolved the identified issues and that metrics are moving to target or are at target.
• Confirm retained-sample and traceability records meet the documented requirements and close any remaining gaps.
• Agree which open change requests will enter the queued enhancement process and which require immediate operational changes.
• Publish a 90-day stabilization report summarizing metric trends, remediation status, and any remaining open items.
• Complete the retained-sample reconciliation and update the traceability manifest.
• Move agreed enhancement requests into the enhancement backlog with priority tags and expected review dates.
• Trend review for key quality metrics
• Maintain or improve batch-to-batch assay variability and COA turnaround time toward the Trial Batch & Lab Evaluation targets.
• Ensure open quality incidents have clear remediation paths and dates to prevent repeat issues.
• Align reorder cadence and replenishment forecasts with the Mutual Commit lead time and minimum order commitments.
• Publish the quarterly quality dashboard with trend charts and the open-issue register.
• Place prioritized enhancement requests into the implementation pipeline with estimated timelines.
• Log all reported incidents in the shared quality tracker and assign remediation tasks with target dates.
• Confirm COA and batch-record distribution channel is functional and documents for the first runs are available.
• Identify and record all immediate production or quality issues and a short remediation plan for each.
• Agree owners for retained-sample storage and traceability verification.
• Publish the first-run COAs and batch records to the agreed shared channel.
• Document retained-sample locations and secure chain-of-custody records for the first runs.
• Present batch results against targets
• Determine whether first-pass COA pass rate meets the Trial Batch & Lab Evaluation target, or document the gap if not.
• Identify the primary root cause(s) for any batch variability and agree concrete corrective actions with deadlines.
• Confirm acceptable COA issuance turnaround time and that the sharing channel meets buyer needs.
• Produce a short corrective action plan for any failed batches, listing containment steps and a remediation timeline.
• Adjust the in-process checklist or mixing profile if analysis shows process drift, and publish the revised checklist.
• Publish a COA issuance time log for the measured period and propose any process changes to meet the buyer's cadence.
• Production run validation
• Triage open quality tickets
• Diagnose any deviations
• Review remediation closeout status
• Retained-sample and traceability audit
• Enhancement requests and change control updates
• Containment and corrective actions
• COA and batch-record sharing check
• Early quality signals and incidents
• Confirm COA turnaround and sharing cadence
• Open change requests and enhancement backlog
• Reorder cadence and lead time performance
• Action review and next quarter focus
• Open issues and remediation plan